JACN Did you know that you can get alerts when a new issue is online?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scimeca, J. A.
Right arrow Articles by Miller, G. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scimeca, J. A.
Right arrow Articles by Miller, G. D.
Journal of the American College of Nutrition, Vol. 19, No. 4, 470S-471S (2000)
Published by the American College of Nutrition

Potential Health Benefits of Conjugated Linoleic Acid

Joseph A. Scimeca, PhD and Gregory D. Miller, PhD, FACN

Kraft Foods, Inc., Chicago (J.A.S.), Illinois
National Dairy Council, Rosemont (G.D.M.), Illinois

Address reprint requests to: Gregory D. Miller, Ph.D., National Dairy Council, O’Hare International Center, 10255 W. Higgins Rd., Suite 900, Rosemont, IL 60018-5616. gregorym{at}rosedmi.com.


    INTRODUCTION
 TOP
 INTRODUCTION
 REFERENCES
 
This supplement to the Journal of the American College of Nutrition contains papers that were presented in a symposium entitled Health Benefits of Conjugated Linoleic Acid, which was held on October 2, 1999, in Washington, D.C., as part of the 40th Annual Meeting of the American College of Nutrition. The symposium organizers sought to provide a forum in which to present and discuss the latest research about the potential human health benefits of consuming diets high in conjugated linoleic acid (CLA) to health professionals practicing in the fields of general and clinical nutrition. Although all the data presented at the meeting were based on laboratory animal investigations, the implications for human health are readily apparent and far-reaching.

Presently, CLA is a term used to denote a group of isomers of linoleic acid (cis-9, cis-12-octadecadienoic acid). The characteristic that binds these isomers together is that, unlike linoleic acid, the two double bonds along the 18-carbon fatty acid chain are not separated by a methylene carbon and, hence, are termed "conjugated." Of the many positional and geometric isomers of CLA that are possible, the cis-9, trans-11-octadecadienoic acid isomer predominates in food products [1]. This isomer is naturally rich in milk fat, being produced by rumen bacteria during the process of biohydrogenation. The reader is encouraged to read Griinari and Bauman [2] for a review of the biosynthesis of CLA.

The history of conjugated linoleic acid extends back to the 1930s, when the presence of fatty acids obtained from butter fat was reported to exhibit spectrophotometric absorption at 230 µm, thus indicating the presence of two conjugated double bonds. It was not until the advent of gas liquid chromotography, that Peter Parodi and others were able to fractionate the methyl esters of milk fat and hence were able to quantitatively determine some of the isomers of CLA, including the cis-9, trans-11-octadecadienoic acid isomer, which has the proposed name of rumenic acid. For an excellent historical summary of the discovery of CLA in milk fat, the reader is referred to a review by Parodi [3].

The turning point in CLA research can be traced back to investigations by Michael Pariza that revealed the presence of "mutagenesis inhibitory" activity in extracts of grilled ground beef [4]. Subsequent research established that the extract exhibited anticarcinogenesis activity as well [5] and that the identity of the active principle was CLA [6]. These studies have led to hundreds of investigations and the recognition of multiple biological effects of CLA. The symposium organizers selected five areas of CLA research to highlight in the symposium: inhibition of mammary cancer, retardation and regression of atherosclerosis, modification of body fat metabolism and partitioning, anti-diabetic effect and enhancement of bone formation.

This supplemental section includes three of the five papers presented at the symposium. Not included in the supplement are papers by Drs. Clement Ip and Karen Houseknecht. Both investigators have recently published papers that include much of the material they presented during the symposium. Clement Ip’s presentation focused on research which demonstrated for the first time that naturally-occurring CLA in a food form had biological activity and that this activity was similar to that produced by a mixture of CLA isomers delivered as free fatty acids [7]. Karen Houseknecht’s research extends to the original observation of an anti-diabetic effect by dietary CLA using the Zucker diabetic fatty rat model [8], and her presentation included research that was recently published on the mode of action(s) by which CLA was responsible for the anti-diabetic effect [911].

The first of the papers in this supplement is by David Kritchevsky and contains research that examined the effect of CLA on the establishment and progression of atherosclerosis in rabbits. It is interesting to note that Dr. Kritchevsky’s research provides evidence that not all trans fatty acids may similarly contribute to cardiovascular disease. The next paper is authored by Drs. Bruce Watkins and Mark Seifert and reviews bone biology and the effects of dietary factors such as CLA on bone metabolism. The last paper is by Dr. James DeLany and colleagues and examines changes in body composition with CLA consumption.

The supplement editors hope that the reader of this supplement finds the information interesting and is able to gain a better understanding of the potential human health benefits of consuming diets high in CLA.


    FOOTNOTES
 
Dr. Scimeca’s current address: The Pillsbury Company, Pillsbury Technology Center East, 737 Pelham Blvd, St. Paul MN 55114.

Received February 1, 2000.
    REFERENCES
 TOP
 INTRODUCTION
 REFERENCES
 

  1. Chin SF, Liu W, Storkson JM, Ha YL, Pariza MW: Dietary sources of conjugated dienoic isomers of linoleic acid, a newly recognized class of anticarcinogens. J Food Compos Anal 5: 185–187, 1992.
  2. Griinari JM, Bauman DE: Biosynthesis of conjugated linoleic acid in its incorporation into meat and milk ruminants. In Yurawecz MP, Mossaba MM, Kramer JKG, Pariza MW, Nelson GJ (eds): "Advances in Conjugated Linoleic Acid Research, Volume 1." Champaign, IL: AOCS Press, pp 180–200, 1999.
  3. Parodi PW: Conjugated linoleic acid: the early years. In Yurawecz MP, Mossaba MM, Kramer JKG, Pariza MW, Nelson GJ (eds): "Advances in Conjugated Linoleic Acid Research, Volume 1." Champaign, IL: AOCS Press, pp 180–200, 1999.
  4. Pariza MW, Ashoor SH, Chu FS, Lund DB: Effects of temperature and time on mutagen formation in pan-fried hamburger. Cancer Lett 7: 63–69, 1979.[Medline]
  5. Pariza MW, Hargraves WA: A beef-derived mutagenesis modulator inhibits initiation of mouse epidermal tumors by 7,12-dimethylbenz[a]anthracene. Carcinogenesis 6: 591–593, 1985.[Abstract/Free Full Text]
  6. Ha YL, Grimm NK, Pariza MW: Anticarcinogens from fried ground beef: heat-altered derivatives of linoleic acid. Carcinogenesis 8: 1881–1887, 1987.[Abstract/Free Full Text]
  7. Ip C, Banni S, Angioni E, Carta G, McGinley J, Thompson HJ, Barbano D, Bauman D: Conjugated linoleic acid-enriched butter fat alters mammary gland morphogenesis and reduces cancer risk in rats. J Nutr 129: 2135–2142, 1999.[Abstract/Free Full Text]
  8. Housekneckt KL, Vanden Heuval JP, Moya-Camerena SY, Portocarrero CP, Peck LW, Nickel KP, Belury MA: Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem Biophys Res Commun 244: 678–682, 1998.[Medline]
  9. Ryder J, Bauman DE, Portocarrero C, Song X, Yu M, Barbano D, Zierath J, Houseknecht K: Anti-diabetic effects of dietary conjugated linoleic acid (CLA): isomer-specific effects on glucose tolerance and skeletal muscle transport. (Abstract) 1999 American Society of Animal Science Meeting, July 21–23, 1999, Indianapolis, IN.
  10. Ryder J, Bauman DE, Portocarrero CP, Song X, Yu M, Zierath JR, Houseknecht KL: Dietary conjugated linoleic acid (CLA) improves glucose tolerance and glucose uptake into skeletal muscle of Zucker diabetic fatty (ZDF) rats. (Abstract) American Diabetes Association 59th Annual Meeting, June 19–22, 1999, San Diego, CA.
  11. Portocarrero CP, Bauman DE, Barbano DM, Zierath JR, Houseknecht KL: Regulation of UCP1 and UCP2 gene expression by dietary conjugated linoleic acid (CLA) in Zucker diabetic fatty (ZDF) rats. (Abstract) American Diabetes Association 59th Annual Meeting, June 19–22, 1999, San Diego, CA.



This article has been cited by other articles:


Home page
J. Am. Coll. Nutr.Home page
G. D. Miller, J. K. Jarvis, and L. D. McBean
The Importance of Meeting Calcium Needs with Foods
J. Am. Coll. Nutr., April 1, 2001; 20(2): 168S - 185.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scimeca, J. A.
Right arrow Articles by Miller, G. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scimeca, J. A.
Right arrow Articles by Miller, G. D.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS